Cargando…

Long-term Efficacy of Perampanel in a Child with Dravet Syndrome

Dravet syndrome is a genetic developmental and epileptic encephalopathy (DEE) mostly due to mutations in SCN1A gene. Perampanel is a selective and non-competitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist. There is increasing experience in the use of perampa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turón-Viñas, Eulàlia, Díaz-Gómez, Asunción, Coca, Elisabet, Dougherty, Lucía, Ruiz, Carlos, Boronat, Susana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532213/ https://www.ncbi.nlm.nih.gov/pubmed/34692895 http://dx.doi.org/10.1177/2329048X211050711

Ejemplares similares

Perampanel Reduces Hyperthermia-Induced Seizures in Dravet Syndrome Mouse Model
por: Ho, Shih-Yin, et al.
Publicado: (2021)

Efficacy of perampanel in a patient with epilepsia partialis continua
por: Argente-Escrig, H., et al.
Publicado: (2017)

Double somatic mosaicism in a child with Dravet syndrome
por: Muir, Alison M., et al.
Publicado: (2019)

Eculizumab in a child with atypical haemolytic uraemic syndrome and haemophagocytic lymphohistiocytosis triggered by cytomegalovirus infection
por: Fraga-Rodriguez, Gloria M, et al.
Publicado: (2017)

Perampanel and pregnancy
por: Vazquez, Blanca, et al.
Publicado: (2021)

Dravet syndrome
por: Incorpora, Gemma
Publicado: (2009)

Lance-Adams Syndrome Treated by Perampanel in the Acute Term
por: Katsuki, Masahito, et al.
Publicado: (2021)

Efficacy and adverse reactions of perampanel in the treatment of epilepsy in children
por: Li, Dan, et al.
Publicado: (2022)

Efficacy of perampanel as an adjunctive therapy in pediatric focal epilepsy
por: Zhang, Wei-Ran, et al.
Publicado: (2023)

Does long‐term phenytoin have a place in Dravet syndrome?
por: Zographos, George A., et al.
Publicado: (2022)

Vaccinations and Dravet Syndrome
por: Korff, Christian M.
Publicado: (2015)

Phenotypes of Dravet Syndrome
por: Garcia-Sosa, Rebecca, et al.
Publicado: (2016)

Dravet Syndrome: An Overview
por: Anwar, Arsalan, et al.
Publicado: (2019)

Stiripentol for Dravet syndrome
Publicado: (2020)

Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology
por: Catarino, Claudia B., et al.
Publicado: (2011)

Perampanel efficacy and tolerability with enzyme-inducing AEDs in patients with epilepsy
por: Gidal, Barry E., et al.
Publicado: (2015)

Efficacy of perampanel in pediatric epilepsy with known and presumed genetic etiology
por: Miao, Pu, et al.
Publicado: (2023)

Efficacy and Tolerability of Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review
por: Rossi, Jessica, et al.
Publicado: (2023)

The Efficacy of Ketogenic Diet in 60 Chinese Patients With Dravet Syndrome
por: Tian, Xiaojuan, et al.
Publicado: (2019)

Perampanel in lissencephaly-associated epilepsy
por: Ikemoto, Satoru, et al.
Publicado: (2019)

“Zombielike” Aggression in Perampanel Overdose
por: Morsi, Rami Z, et al.
Publicado: (2021)

Complete Resolution of Symptoms of Primary Orthostatic Tremor with Perampanel
por: Ruiz-Julián, María, et al.
Publicado: (2018)

Assessment of the long‐term efficacy and safety of adjunctive perampanel in tonic‐clonic seizures: Analysis of four open‐label extension studies
por: Rektor, Ivan, et al.
Publicado: (2020)

Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial
por: Devinsky, Orrin, et al.
Publicado: (2018)

Crouch Gait in Dravet Syndrome
por: Black, Laura, et al.
Publicado: (2016)

Anesthetic considerations in Dravet syndrome
por: Macdonald‐Laurs, Emma, et al.
Publicado: (2022)

Open the Window for the Cure of Dravet
por: Gu, Bin
Publicado: (2022)

Efficacy of Stiripentol in Dravet Syndrome with or without SCN1A Mutations
por: Cho, Min Jung, et al.
Publicado: (2018)

Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome
por: Anderson, Lyndsey L., et al.
Publicado: (2017)

Long‐term open‐label perampanel: Generalized tonic–clonic seizures in idiopathic generalized epilepsy
por: French, Jacqueline A., et al.
Publicado: (2022)

Long-term efficacy and safety of adjunctive perampanel in pediatric patients aged 4–19 years with epilepsy: a real-world study
por: Youn, Song Ee, et al.
Publicado: (2023)

Add-on perampanel in Lance–Adams syndrome
por: Steinhoff, Bernhard J., et al.
Publicado: (2016)

Adjunctive perampanel for glioma-associated epilepsy()
por: Dunn-Pirio, Anastasie M., et al.
Publicado: (2018)

Current role of perampanel in pediatric epilepsy
por: De Liso, Paola, et al.
Publicado: (2017)

Perampanel and Visuospatial Skills in Children With Epilepsy
por: Operto, Francesca Felicia, et al.
Publicado: (2021)

Do All Roads Lead to Rome? Genes Causing Dravet Syndrome and Dravet Syndrome-Like Phenotypes
por: Ding, Jiangwei, et al.
Publicado: (2022)

Intravenous Perampanel as an Interchangeable Alternative to Oral Perampanel: A Randomized, Crossover, Phase I Pharmacokinetic and Safety Study
por: Hussein, Ziad, et al.
Publicado: (2022)

Clinical efficacy of perampanel for partial-onset and primary generalized tonic–clonic seizures
por: Besag, Frank MC, et al.
Publicado: (2016)

The Charlotte Project: Recommendations for patient-reported outcomes and clinical parameters in Dravet syndrome through a qualitative and Delphi consensus study
por: Aledo-Serrano, Ángel, et al.
Publicado: (2022)

Hippocampal Proteomic Analysis in Male Mice Following Aggressive Behavior Induced by Long-Term Administration of Perampanel
por: Yang, Wu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1qnssf0tnp62k3semdoc2248sr